Glucagon regulates the stability of REV-ERBα to modulate hepatic glucose production in a model of lung cancer–associated cachexia-Reference-Cited by-同舟云学术

Glucagon regulates the stability of REV-ERBα to modulate hepatic glucose production in a model of lung cancer–associated cachexia

Published:2021-06-25 Issue:26 Volume:7 Page:
ISSN:2375-2548
Container-title:Science Advances
language:en
Short-container-title:Sci. Adv.

Author:

Verlande Amandine¹^ORCID,Chun Sung Kook¹,Goodson Maggie O.¹^ORCID,Fortin Bridget M.¹^ORCID,Bae Hosung¹^ORCID,Jang Cholsoon¹^ORCID,Masri Selma¹^ORCID

Affiliation:

1. Department of Biological Chemistry, Center for Epigenetics and Metabolism, Chao Family Comprehensive Cancer Center, University of California, Irvine (UCI), Irvine, CA 92697, USA.

Abstract

Glucagon signaling governs REV-ERBα stability to modulate hepatic glucose production in a model of lung cancer cachexia.

Funder

National Institutes of Health

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

Reference80 articles.

1. Circadian Clocks and Cancer: Timekeeping Governs Cellular Metabolism

2. Molecular architecture of the mammalian circadian clock

3. BMAL1 and CLOCK, Two Essential Components of the Circadian Clock, Are Involved in Glucose Homeostasis

4. Muscle insulin sensitivity and glucose metabolism are controlled by the intrinsic muscle clock

5. Lipidomics Analyses Reveal Temporal and Spatial Lipid Organization and Uncover Daily Oscillations in Intracellular Organelles

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Embracing cancer complexity: Hallmarks of systemic disease;Cell;2024-03

2. Progressive, multi‐organ, and multi‐layered nature of cancer cachexia;Cancer Science;2024-01-22

3. Liver as a nexus of daily metabolic cross talk;International Review of Cell and Molecular Biology;2024

4. Targeting NR1D1 in organ injury: challenges and prospects;Military Medical Research;2023-12-11

5. Low albumin status accompanies multi-layered immunosuppressive phenotypes in metastatic breast cancer patients;2023-09-07